Analysis of the risk factors for severity in post endoscopic retrograde cholangiopancreatography pancreatitis: The indication of prophylactic treatments

Table 1 Characterization of patients with post endoscopic retrograde cholangiopancreatography pancreatitis

Variables	Mild-moderate PEP	Severe PEP
Age (yr) (n = 121)
Median	73.7	76.5
(range)	(18-93)	(32-88)
Gender (n = 121)
Male/female	57/50	7/7
BMI (kg/m2) (n = 121)
Median	21.6	23.2
(range)	(13.97-35.20)	(14.79-29.5)
Smoking status (n = 121)
Non-smoker/Ex- or current smoker	83/24	7/7
Drinking status (n = 121)
Absent/present	67/40	12/2
Past history (n = 121)
Absent/present	31/76	4/10
Malignant disease (n = 121)
Absent/present	84/23	10/4
History of pancreatitis (n = 121)
Absent/present	106/1	1/13
SOD (n = 121)
Absent/present	101/6	1/13
Diverticulum nearby vater papilla (n = 121)
Absent/present	70/37	11/3
CBD diameter of patient with CBD stones (n = 41)
≥ 10 mm/< 10 mm	21/16	2/2

PEP: Post endoscopic retrograde cholangiopancreatography pancreatitis; BMI: Body mass index; SOD: Sphincter of Oddi dysfunction; CBD: Common bile duct.